Cargando…

Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma

Background: Increasing evidence indicates that early radiation-induced subtle cerebral changes may be the precursors to permanent brain dysfunction at the late-delayed (LDS) post-radiotherapy (RT) stage. In this study, we aim to track the RT-related longitudinal brain activity in nasopharyngeal carc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yadi, Lin, Xiaoshan, Li, Jing, Han, Lujun, Li, Zhipeng, Liu, Shiliang, Hou, Gangqiang, Xie, Chuanmiao, Lv, Xiaofei, Qiu, Yingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660255/
https://www.ncbi.nlm.nih.gov/pubmed/31379710
http://dx.doi.org/10.3389/fneur.2019.00752
_version_ 1783439278143963136
author Yang, Yadi
Lin, Xiaoshan
Li, Jing
Han, Lujun
Li, Zhipeng
Liu, Shiliang
Hou, Gangqiang
Xie, Chuanmiao
Lv, Xiaofei
Qiu, Yingwei
author_facet Yang, Yadi
Lin, Xiaoshan
Li, Jing
Han, Lujun
Li, Zhipeng
Liu, Shiliang
Hou, Gangqiang
Xie, Chuanmiao
Lv, Xiaofei
Qiu, Yingwei
author_sort Yang, Yadi
collection PubMed
description Background: Increasing evidence indicates that early radiation-induced subtle cerebral changes may be the precursors to permanent brain dysfunction at the late-delayed (LDS) post-radiotherapy (RT) stage. In this study, we aim to track the RT-related longitudinal brain activity in nasopharyngeal carcinoma (NPC) patients and to determine whether early abnormal brain activity can predict late neurocognitive dysfunction after RT. Methods: Thirty-three NPC patients were finally included and longitudinally followed up at the following time points: prior to treatment initiation, early-delayed stage (EDS, 1–3 months), and LDS (six months) after RT. Fifteen comparable healthy controls (HCs) were finally included and followed up in parallel. Montreal Cognitive Assessment (MoCA) was used to assess the general cognitive function. Brain activity was recorded via resting-state fMRI and regional homogeneity (ReHo). A whole-brain voxel-wise-based one-way repeated-measure analysis of variance (ANOVA) was conducted to evaluate the longitudinal ReHo changes among the three time points for NPC patients and HCs, respectively. Results were reported at the significant level of a threshold of two-tailed voxel-wise P < 0.01 and cluster level P < 0.05 with Gaussian Random Field (GRF) correction. Finally, the efficacies of the aberrant ReHo at EDS for predicting the cognitive impairment at LDS in NPC patients were evaluated. Results: Significant differences were detected in ReHo among the three time points in NPC patients but not in HCs. Aberrant ReHo was distributed in the bilateral cerebellum, the right temporal lobe, and the left insular areas, which showed different dynamic changes patterns over time. Logistic regression model combining the mean ReHo, age, and irradiation dose on the bilateral temporal lobe had the highest diagnostic efficiency according to the area under the curve (AUC) score (AUC = 0.752, P = 0.023). Conclusions: The post-RT brain activity revealed by ReHo in NPC patients was dynamic, complex, and multifactorial. Furthermore, the combination of the aberrant ReHo at EDS, age, and irradiation dose may serve as a potential biomarker of the RT-induced cognitive impairments at LDS.
format Online
Article
Text
id pubmed-6660255
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66602552019-08-02 Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma Yang, Yadi Lin, Xiaoshan Li, Jing Han, Lujun Li, Zhipeng Liu, Shiliang Hou, Gangqiang Xie, Chuanmiao Lv, Xiaofei Qiu, Yingwei Front Neurol Neurology Background: Increasing evidence indicates that early radiation-induced subtle cerebral changes may be the precursors to permanent brain dysfunction at the late-delayed (LDS) post-radiotherapy (RT) stage. In this study, we aim to track the RT-related longitudinal brain activity in nasopharyngeal carcinoma (NPC) patients and to determine whether early abnormal brain activity can predict late neurocognitive dysfunction after RT. Methods: Thirty-three NPC patients were finally included and longitudinally followed up at the following time points: prior to treatment initiation, early-delayed stage (EDS, 1–3 months), and LDS (six months) after RT. Fifteen comparable healthy controls (HCs) were finally included and followed up in parallel. Montreal Cognitive Assessment (MoCA) was used to assess the general cognitive function. Brain activity was recorded via resting-state fMRI and regional homogeneity (ReHo). A whole-brain voxel-wise-based one-way repeated-measure analysis of variance (ANOVA) was conducted to evaluate the longitudinal ReHo changes among the three time points for NPC patients and HCs, respectively. Results were reported at the significant level of a threshold of two-tailed voxel-wise P < 0.01 and cluster level P < 0.05 with Gaussian Random Field (GRF) correction. Finally, the efficacies of the aberrant ReHo at EDS for predicting the cognitive impairment at LDS in NPC patients were evaluated. Results: Significant differences were detected in ReHo among the three time points in NPC patients but not in HCs. Aberrant ReHo was distributed in the bilateral cerebellum, the right temporal lobe, and the left insular areas, which showed different dynamic changes patterns over time. Logistic regression model combining the mean ReHo, age, and irradiation dose on the bilateral temporal lobe had the highest diagnostic efficiency according to the area under the curve (AUC) score (AUC = 0.752, P = 0.023). Conclusions: The post-RT brain activity revealed by ReHo in NPC patients was dynamic, complex, and multifactorial. Furthermore, the combination of the aberrant ReHo at EDS, age, and irradiation dose may serve as a potential biomarker of the RT-induced cognitive impairments at LDS. Frontiers Media S.A. 2019-07-16 /pmc/articles/PMC6660255/ /pubmed/31379710 http://dx.doi.org/10.3389/fneur.2019.00752 Text en Copyright © 2019 Yang, Lin, Li, Han, Li, Liu, Hou, Xie, Lv and Qiu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Yang, Yadi
Lin, Xiaoshan
Li, Jing
Han, Lujun
Li, Zhipeng
Liu, Shiliang
Hou, Gangqiang
Xie, Chuanmiao
Lv, Xiaofei
Qiu, Yingwei
Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
title Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
title_full Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
title_fullStr Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
title_full_unstemmed Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
title_short Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
title_sort aberrant brain activity at early delay stage post-radiotherapy as a biomarker for predicting neurocognitive dysfunction late-delayed in patients with nasopharyngeal carcinoma
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660255/
https://www.ncbi.nlm.nih.gov/pubmed/31379710
http://dx.doi.org/10.3389/fneur.2019.00752
work_keys_str_mv AT yangyadi aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT linxiaoshan aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT lijing aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT hanlujun aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT lizhipeng aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT liushiliang aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT hougangqiang aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT xiechuanmiao aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT lvxiaofei aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT qiuyingwei aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma